Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Arpirin in Preventing Venous Thromboembolism in Total Knee and Hip Replacement

NCT06635317 is registered in ClinicalTrials.gov with Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado as lead sponsor.

NCT NCT06635317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06635317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Arpirin in Preventing Venous Thromboembolism in Total Knee and Hip Replacement
Lead sponsor
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
Phase
Phase 4
Overall status
Completed
Start date
April 24, 2022
Completion date
February 28, 2023
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

total hip arthroplasty (tha), total joint arthroplasty, venous thromboembolism (vte)